The company's financial position reflects significant asset contraction, with goodwill falling from $108.4M in 2023Q4 to $22.1M in 2026Q1, signaling potential impairment of past acquisitions.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'05 |
|---|
| Total Current Assets | 470.54M | 476.17M | 341.57M | 535.11M | 604.18M | 693.52M | 147.16M | 102.97M | 51.77M | 17.3M | 6.1M | 6.21M | 2.16M | 1.11M | 958.3K | 5.13M | 10M | 3.91M | 1.54M | 3.35M | 435.89K | 292.85K | 966.84K | 966.84K |
| Cash & Short-Term Investments | 403.63M | 411.21M | 261.75M | 456.75M | 523.32M | 628.8M | 93.32M | 94.3M | 47.26M | 15.04M | 4.52M | 5.25M | 1.41M | 369.58K | 563.1K | 4.62M | 9.28M | 3.63M | 776.17K | 2.79M | 264.39K | 41.39K | 720.2K | 720.2K |
| Cash Only | 272.91M | 250.49M | 45.29M | 46.35M | 36.59M | 139.1M | 36.87M | 47.23M | 37.33M | 15.04M | 5.25M | 5.25M | 1.41M | 369.58K | 563.1K | 4.62M | 9.28M | 3.63M | 776.17K | 2.79M | 264.39K | 41.39K | 720.2K | 720.2K |
| Short-Term Investments | 130.72M | 160.71M | 216.46M | 410.41M | 486.73M | 489.7M | 56.44M | 47.06M | 9.93M | 0 | -2.79B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 39M | 33.36M | 45.78M | 42.07M | 43.86M | 39.41M | 31.38M | 7.1M | 3.54M | 1.63M | 1.2M | 616.78K | 589.7K | 515.83K | 217.1K | 146.12K | 55.79K | 78.04K | 4.82K | 32.59K | 10.17K | 47.83K | 44.55K | 44.55K |
| Days Sales Outstanding | 67.66 | 69.11 | 71.63 | 64.72 | 71.91 | 64.62 | 145.53 | 76.33 | 65.9 | 49.63 | 56.83 | 38.27 | 54.69 | 70.78 | 72 | 95.99 | 42.83 | 241.47 | 50.11 | 142.34 | 55.33 | 114.62 | 59.9 | 59.9 |
| Inventory | 21.75M | 23.19M | 22.47M | 26.21M | 27.68M | 16.5M | 10.54M | 474K | 220.51K | 114.8K | 89.5K | 52.88K | 69.68K | 29.7K | 39.21K | 51.75K | 44.22K | 0 | 533.2K | 151.01K | 146.01K | 189.86K | 150.98K | 150.98K |
| Days Inventory Outstanding | 86.52 | 90.89 | 61.24 | 71.7 | 80.16 | 47.79 | 90.77 | 10.43 | 8.58 | 7 | 7.14 | 4.84 | 9.19 | 4.88 | 9.01 | 13.57 | 12.39 | - | 356.35 | 142.66 | 301.19 | 219.55 | 110.29 | 110.29 |
| Other Current Assets | 6.15M | 8.42M | 11.57M | 10.08M | 9.32M | 0 | 0 | 0 | 0 | 0 | 0 | 288.96K | 0 | 196.5K | 138.89K | 317.34K | 528.04K | 0 | 100.48K | 201.47K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 293.07M | 288.81M | 361.92M | 422.63M | 434.57M | 419.45M | 405.25M | 32.91M | 4.85M | 2.97M | 2.02M | 1.25M | 444.75K | 598.34K | 797.49K | 1.08M | 1.03M | 871.21K | 670.12K | 807.2K | 47.8K | 89.74K | 113.59K | 113.59K |
| Property, Plant & Equipment | 129.1M | 125.17M | 136.03M | 117.51M | 90.48M | 69.7M | 44.08M | 16.29M | 4.36M | 2.51M | 1.65M | 875.67K | 307.93K | 408.89K | 505.49K | 682.02K | 669.58K | 559.24K | 204.47K | 198.87K | 38.4K | 79.21K | 96.94K | 96.94K |
| Fixed Asset Turnover | 1.47x | 1.41x | 1.71x | 2.02x | 2.46x | 3.19x | 1.79x | 2.08x | 4.50x | 4.76x | 4.66x | 6.72x | 12.78x | 6.51x | 2.18x | 0.81x | 0.71x | 0.21x | 0.17x | 0.42x | 1.75x | 1.92x | 2.80x | 2.80x |
| Goodwill | 22.14M | 22.4M | 51.66M | 108.4M | 151.12M | 146.95M | 145.28M | 11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -354.5M | -311.65M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 138.72M | 138.08M | 170.46M | 194.38M | 191.01M | 201.43M | 213.91M | 5.18M | 137.22K | 90.65K | 5K | 13.48K | 136.82K | 180.09K | 272.26K | 379.08K | 354.85M | 311.96M | 278.52K | 1.2K | 9.39K | 10.53K | 16.65K | 16.65K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.05M | 2.09M | 2.9M | 1.68M | 1.02M | 950K | 1.98M | 437K | 350.84K | 363.4K | 363.4K | 363.4K | 0 | 9.36K | 19.74K | 19.74K | 9.36K | 0 | 187.13K | 607.13K | 0 | 0 | 0 | 0 |
| Total Assets | 763.61M | 764.99M | 703.49M | 957.74M | 1.04B | 1.11B | 552.4M | 135.87M | 56.62M | 20.26M | 8.11M | 7.46M | 2.61M | 1.71M | 1.76M | 6.21M | 11.03M | 4.78M | 2.21M | 4.16M | 483.69K | 382.59K | 1.08M | 1.08M |
| Asset Turnover | 0.24x | 0.23x | 0.33x | 0.25x | 0.21x | 0.20x | 0.14x | 0.25x | 0.35x | 0.59x | 0.95x | 0.79x | 1.51x | 1.56x | 0.63x | 0.09x | 0.04x | 0.02x | 0.02x | 0.02x | 0.14x | 0.40x | 0.25x | 0.25x |
| Asset Growth % | 10.3% | 8.74% | -26.55% | -7.8% | -6.67% | 101.48% | 306.56% | 139.97% | 179.41% | 149.81% | 8.76% | 186.14% | 52.44% | -2.61% | -71.74% | -43.67% | 130.95% | 115.77% | -46.77% | 759.88% | 26.43% | -64.59% | - | - |
| Total Current Liabilities | 224.87M | 219.02M | 64.56M | 45.61M | 40.85M | 42.65M | 35.02M | 5.46M | 3.06M | 2.19M | 2.23M | 2.47M | 3M | 4.01M | 2.5M | 1.11M | 3.24M | 1.91M | 3.52M | 1.48M | 914.29K | 670.6K | 607.96K | 607.96K |
| Accounts Payable | 15.94M | 15.28M | 26.17M | 26.05M | 27.05M | 28.58M | 24.84M | 2.5M | 1.64M | 1.2M | 1.16M | 758.7K | 758.7K | 579.68K | 858.71K | 401.4K | 506.89K | 823.65K | 331.96K | 234.82K | 306.68K | 174.16K | 162.99K | 162.99K |
| Days Payables Outstanding | 55.3 | 59.9 | 71.32 | 71.29 | 78.33 | 82.78 | 214.06 | 54.96 | 63.91 | 73.35 | 92.52 | 69.37 | 100.1 | 95.18 | 197.4 | 105.22 | 141.99 | 418.88 | 221.86 | 221.83 | 632.64 | 201.39 | 119.06 | 119.06 |
| Short-Term Debt | 189.61M | 189.81M | 14.44M | 149K | 60K | 0 | 0 | 0 | 0 | 0 | 651.93K | 981.99K | 1.51M | 2.98M | 1.4M | 433.9K | 2.17M | 440.39K | 2.88M | 856K | 285.44K | 54K | 24K | 24K |
| Deferred Revenue (Current) | 6.48M | 943K | 1.11M | 1.31M | 439K | 547K | 445K | 368K | 66.31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 12.98M | 3.71M | 3.8M | 3.45M | 1.91M | 1.39M | 518K | 0 | 56.27K | 0 | 350.55K | 0 | 0 | 20.85K | 0 | 156.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 2.09x | 2.17x | 5.29x | 11.73x | 14.79x | 16.26x | 4.20x | 18.85x | 16.91x | 7.92x | 2.73x | 2.51x | 0.72x | 0.28x | 0.38x | 4.63x | 3.09x | 2.04x | 0.44x | 2.27x | 0.48x | 0.44x | 1.59x | 1.59x |
| Quick Ratio | 2.00x | 2.07x | 4.94x | 11.16x | 14.11x | 15.88x | 3.90x | 18.77x | 16.84x | 7.86x | 2.69x | 2.49x | 0.70x | 0.27x | 0.37x | 4.58x | 3.07x | 2.04x | 0.29x | 2.17x | 0.32x | 0.15x | 1.34x | 1.34x |
| Cash Conversion Cycle | 98.89 | 100.1 | 61.56 | 65.14 | 73.74 | 29.63 | 22.24 | 31.8 | 10.57 | -16.72 | -28.56 | -26.26 | -36.21 | -19.52 | -116.38 | 4.34 | -86.78 | - | 184.6 | 63.17 | -276.12 | 132.78 | 51.13 | 51.13 |
| Total Non-Current Liabilities | 43.75M | 43.33M | 237.03M | 423.11M | 442.06M | 428.5M | 134.69M | 4.13M | 15.01M | 192.2K | 200.26K | 0 | 26.45K | 0 | 1.32M | 1.38M | 1.85M | 3.78M | 2.37M | 1.74M | 1.86M | 1.67M | 1.65M | 1.65M |
| Long-Term Debt | 1.03M | 1.09M | 185.03M | 379.89M | 407.06M | 405.26M | 116.26M | 0 | 14.71M | 0 | 0 | 0 | 26.45K | 0 | 1.32M | 1.38M | 421.73K | 2.3M | 2.37M | 1.74M | 1.66M | 35.44K | 43.44K | 43.44K |
| Capital Lease Obligations | 158.75M | 39.82M | 45.32M | 30.31M | 24.94M | 18.2M | 12.37M | 4.11M | 33.16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 4.48M | 1.35M | 2.53M | 2.82M | 4.93M | 4.02M | 5.88M | 21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.29M | 1.07M | 4.14M | 10.1M | 5.13M | 1.03M | 176K | 0 | 267.42K | 192.2K | 200.26K | 0 | 0 | 0 | 0 | 0 | -1.42B | 1.48M | 0 | 0 | 0 | 1.64M | 1.61M | 1.61M |
| Total Liabilities | 268.62M | 262.35M | 301.59M | 468.72M | 482.91M | 471.14M | 169.71M | 9.59M | 18.07M | 2.38M | 2.43M | 2.47M | 3.02M | 4.01M | 3.82M | 2.48M | 5.08M | 5.69M | 5.9M | 3.22M | 2.77M | 2.34M | 2.26M | 2.26M |
| Total Debt | 230.49M | 230.72M | 250.7M | 416M | 435.91M | 427.06M | 130.92M | 4.8M | 14.77M | 0 | 651.93K | 981.99K | 1.54M | 2.98M | 2.72M | 1.81M | 3.34M | 4.22M | 5.25M | 2.59M | 2.14M | 89.44K | 67.44K | 67.44K |
| Net Debt | -42.42M | -19.78M | 205.41M | 369.66M | 399.31M | 287.95M | 94.05M | -42.43M | -22.56M | -15.04M | -4.6M | -4.27M | 133.35K | 2.61M | 2.16M | -4.28M | -6.79M | -1.04M | 4.47M | -196.42K | 1.68M | 48.05K | -652.75K | -652.75K |
| Debt / Equity | 0.47x | 0.46x | 0.62x | 0.85x | 0.78x | 0.67x | 0.34x | 0.04x | 0.38x | - | 0.11x | 0.20x | - | - | - | 0.49x | 0.56x | - | - | 2.75x | - | - | - | - |
| Debt / EBITDA | -22.02x | - | - | - | 180.28x | 176.61x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 4.05x | - | - | - | 165.14x | 119.09x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -16.64x | -15.59x | -17.05x | -4.71x | -57.40x | -57.40x | -11.79x | -12.37x | -136.69x | -502.02x | -98.88x | -8.21x | -3.92x | -23.94x | -86.58x | -13.84x | -8.94x | 0.20x | -5.20x | -1.86x | -9.18x | -17.93x | -11.07x | -11.07x |
| Total Equity | 494.99M | 502.64M | 401.9M | 489.02M | 555.84M | 641.83M | 382.7M | 126.28M | 38.55M | 17.89M | 5.68M | 4.99M | -416.3K | -2.3M | -2.06M | 3.73M | 5.95M | -914.58K | -3.68M | 943.99K | -2.29M | -1.96M | -1.18M | -1.18M |
| Equity Growth % | 71.49% | 25.07% | -17.82% | -12.02% | -13.4% | 67.71% | 203.05% | 227.61% | 115.5% | 214.89% | 13.83% | 1298.72% | 81.94% | -11.69% | -155.32% | -37.3% | 750.4% | 75.17% | -490.22% | 141.26% | -16.66% | -66.19% | - | - |
| Book Value per Share | 9.92 | 10.04 | 8.25 | 9.98 | 12.10 | 13.97 | 9.92 | 3.78 | 1.37 | 0.78 | 0.40 | 0.63 | -0.08 | -0.53 | -0.61 | 1.44 | 5.01 | -2.04 | -10.00 | 2.68 | -8.28 | -7.35 | -7.38 | -7.38 |
| Total Shareholders' Equity | 494.99M | 502.64M | 401.9M | 489.02M | 555.84M | 641.83M | 382.7M | 126.28M | 38.55M | 17.89M | 5.68M | 4.99M | -416.3K | -2.3M | -2.06M | 3.73M | 5.95M | -914.58K | -3.68M | 943.99K | -2.29M | -1.96M | -1.18M | -1.18M |
| Common Stock | 0 | 50K | 50K | 49K | 48K | 50K | 40K | 37K | 30.32K | 25.7K | 17.6K | 7.25K | 5.03K | 5K | 37.76K | 37.76K | 27.5K | 8.14K | 41.3K | 39.98K | 34.78K | 29.94K | 29.71K | 29.71K |
| Retained Earnings | 0 | -688.88M | -757.17M | -642.42M | -542.83M | -467.54M | -192.01M | -159.32M | -140.99M | -131.43M | -123.53M | -109.35M | -97.77M | -85.88M | -66.31M | -59.93M | -52.1M | -45.94M | -25.18M | -11.96M | -9.37M | -6.69M | -5.52M | -5.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -3.48M | -20.93M | -26.07M | -34.55M | -1.24M | 5.38M | -45K | 3.15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -253.37K | -478.66K | 0 | -437.69K | -337.1K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biotech funding cycle sensitivity
As reported in financial statements, Cryoport's total assets have declined from $957.7M in 2023Q4 to $763.6M by 2026Q1, reflecting a significant contraction in the company's resource base that mirrors the broader downturn in clinical trial activity and the subsequent reduction in operational scale.
The downward trend in total assets suggests that the company is struggling to maintain its previous footprint amidst a challenging biotech funding environment. Investors should monitor whether this reduction represents a strategic rightsizing of the asset base or a forced liquidation of value due to persistent operational losses.
Based on reported figures, Cryoport's debt-to-equity ratio fluctuated significantly, peaking at 1.01 in 2024Q2 before moderating to 0.47 in 2026Q1, indicating that while leverage has been reduced, the company remains heavily reliant on debt to sustain its capital-intensive logistics infrastructure during periods of revenue decline.
The reliance on debt to fund operations in the absence of consistent positive cash flow warrants further investigation into the company's long-term solvency. The shift in leverage metrics appears to be driven more by equity adjustments and asset management than by a fundamental improvement in debt-servicing capacity.
According to recent SEC filings, the company's cash position saw a notable recovery to $272.9M in 2026Q1 from a low of $36.1M in 2025Q2, providing a temporary liquidity buffer that may mitigate immediate concerns regarding the company's ability to cover its ongoing operational burn.
While the current cash position appears improved, the historical volatility in liquidity suggests that the company remains vulnerable to sudden shifts in working capital requirements. Analysts should interpret this cash accumulation with caution, as it may be the result of financing activities rather than organic operational success.
As indicated by the balance sheet data, goodwill has plummeted from $108.4M in 2023Q4 to $22.1M in 2026Q1, which suggests that previous acquisitions have failed to meet performance expectations, leading to significant write-downs that have materially impacted the company's reported equity value.
The rapid erosion of goodwill highlights the risks inherent in the company's aggressive M&A strategy and raises questions about the quality of the assets currently held on the balance sheet. This trend may indicate that the company's past growth-at-all-costs approach has left it with overvalued intangible assets that are now being corrected.
Quick answers to the most common questions about buying CYRX stock.
As of 2025, Cryoport, Inc. (CYRX) had total assets of $765.0M including $476.2M in current assets.
Cryoport, Inc. (CYRX) carries total debt of $230.7M, offset by $411.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cryoport, Inc. (CYRX) has total shareholders' equity (book value) of $502.6M ($10.04 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cryoport, Inc. (CYRX) reported a current ratio of 2.17x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.